The STAAR Vision EVO Implantable Collamer Lens (ICL) is a leading-edge option in refractive surgery designed for patients seeking freedom from glasses or contact lenses. Unlike LASIK, the EVO ICL is an additive lens implanted behind the iris, without removing any corneal tissue, making it a versatile option for patients with thin corneas or high prescriptions. Made from biocompatible collamer material, it naturally works with the eye to correct nearsightedness and astigmatism, offering sharp, clear vision at all distances. The procedure is quick, and the lens can be removed or replaced if needed, providing long-term flexibility. Ideal for patients looking for a safe, effective, and reversible alternative to LASIK, the EVO ICL delivers a high-quality vision solution for those who may not qualify for other refractive surgeries.
The EVO ICL is especially suited for those with higher levels of nearsightedness, generally in the range of -3.00 to -20.00 diopters, and for whom LASIK might not be as effective or recommended.
Since the ICL does not involve removing corneal tissue, it’s an excellent option for patients with thinner corneas or irregularities that may make them unsuitable for LASIK or PRK.
Unlike LASIK, the ICL can be removed or replaced, making it a good choice for those seeking a flexible, potentially reversible vision correction option.
Candidates should have stable vision, meaning their prescription hasn’t changed significantly in the past year or so.
This is typically the ideal age range for ICL implantation, though other factors may also come into play for older candidates.
Candidates should have no history of eye diseases like glaucoma, iritis, or diabetic retinopathy, and should not have previous major eye surgery.
For patients meeting these criteria, the EVO ICL can offer a high-quality, long-term vision correction alternative, especially for those who may not qualify for LASIK or prefer a non-permanent solution.
The Implantable Collamer Lens (ICL) procedure is a quick and minimally invasive surgery that typically takes about 20-30 minutes per eye. Here’s what patients can expect during the process:
Most patients can resume regular activities within a day or two, although strenuous activities should be avoided for a short period. Follow-up appointments are scheduled to monitor healing and ensure optimal positioning of the ICL.